Regenstrief Institute Jun 25 2025 A new multi-state study led by the Centers for Disease Control and Prevention's (CDC) VISION Network – including Regenstrief Institute – has provided the most comprehensive assessment to date of the effectiveness of 2023-2024 COVID-19 vaccines among adults in the U.S. during the XBB and JN.1 Omicron subvariant waves. Data suggest that receiving updated COVID-19 vaccines remains crucial, especially for older adults and those at increased risk for severe outcomes,

Tag-uri: Coronavirus